The Nordic impact stocks enjoyed a week of mixed performance as Energy Production & Storage rose 5%, while the Mobility sector declined 6%. The whole
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. In the past week, the Nordic biotech and healthcare stocks
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. In the past week, the Nordic biotech and healthcare stocks
In the past week, the Nordic impact stocks declined 4% on average. Especially three sectors were severely hit with 4-7% declines following drawdowns in individual
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. In the past week, the Nordic biotech and healthcare stocks
Through a private placement at market price, FluoGuide raises SEK 60M to initiate planned Phase II trials and trigger the first price trigger. Positive price
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week, the KPHC fell 2.2%, and the Danish
The Mobility sector is the one and only this year performing exceptionally well with a 38% return year-to-date. Clean Motion continues with very strong momentum
Curasight is off to a great start in 2024 with a milestone payment from Curium. After a whirlwind 2023 with a 74% share price return
Curasight has received positive results from a Phase 2 study of uTRACE in aggressive brain cancer, validating the technology and opening up combination therapies with
Kapital Partner A/S
Christian IX's Gade 10, 4. th
1111 København K
CVR: 37364843
Kapital Partner performs or has within the last 12 months performed corporate finance, market relations, investor relations, Certified Adviser or other advisory activities for the following listed companies: NORD.investments, Biosergen, InterMail, Pila Pharma, Hypefactors, Curasight, Evaxion, Re-Match, Audientes, Mdundo.com, Nexcom.
Del indlægget på sociale media eller på email.